Learn the key differences between stroke and migraine symptoms, from onset speed to pain patterns, and know exactly when to ...

Switzerland: A recent study published in JAMA Neurology has highlighted key factors influencing the recurrence of ...

Two randomized trials in China find that intra-arterial thrombolysis with urokinase or tenecteplase does not significantly ...

PRESTIGE-AF is the first of the larger trials in this scenario to report results. More data are needed to help guide ...

Intra-arterial thrombolysis via urokinase following reperfusion by endovascular thrombectomy for stroke does not affect survival without disability.

The FDA has approved TNKase, a new, fast-acting stroke treatment that dissolves blood clots more efficiently, marking a significant advancement in stroke therapy and clot-busting technology.

The following is a summary of “Association between SARS-CoV-2 and stroke: perspectives from a metaumbrella-review,” published in the March 2025 issue of BMC Neurology by Baldo de Souza et al. The ...

Among stroke survivors, the risk of developing dementia after stroke is significantly high, highlighting the need for targeted prevention strategies.

FDA, EMA grant BIOX-101 ODD status to treat intracerebral hemorrhagic stroke (ICH) ODD status may expedite drug candidate development and approvals BIOX-101 interim Phase 2a data in ICH imminent ...

A 12-year-old boy in Hanoi is fighting for his life after suffering a severe brain stroke, which followed a sudden onset of symptoms including a headache, vomiting, and drowsiness.